
Doctor of Osteopathy, Kansas City University of Medicine and Biosciences, August 1983 to June 1987.
Residency in Internal Medicine, U.C.L.A. from June 23, 1988, to June 24, 1990.
· Board Certified, Internal Medicine, A.B.I.M. (September 1992)
· Specialty Certification, HIV Medicine, AAHIVM (February 2002)
· Human Participants Protection Education for Research Teams, NIH Online Course (March 2006)
· Human Subject Assurance Training, NIH Online Course (March 2006)
· Lifetime Achievement Award in Health and Science from the Glendale Educational Foundation, Glendale, California (March 2017)
· Certificate of Achievement in 2009 for the highest rating among physicians by patients on a nationally endorsed survey regarding patient experience of care. The award was sponsored by Kansas City Quality Improvement Consortium, United Healthcare, Aetna, and Blue Cross and Blue Shield of Kansas City (August 2009)
· United Healthcare Premium Quality and Efficiency Designation achieved by directing Nemechek Health Renewal (November 2006, 2007, 2008, 2009)
· Nominated for the Greater Kansas City Chamber of Commerce Small Business of the Year Award, Kansas City, Missouri (January 2006, 2007, 2008, 2009)
· Selected as one of 18 clinical sites to participate in the HIV Research Network, managed by the Center for HIV Quality Care of Johns Hopkins Medical Center and funded by AHRQ (June 1999)
· Nominated as one of the top AIDS treating physicians in the United States by POZ Magazine (November 1997)
· Chosen as Site of Clinical Excellence and Case Study for “INTEGRATED PATIENT CARE: Managing Health Care Costs, Maximizing Health Care Value and Quality,” a study sponsored by Bristol-Myers Squibb Company & KPMG Peat Marwick LLP (April 1996)
· Chief Resident, Internal Medicine, U.C.L.A. School of Medicine (June 1989 – June 1990)
· Robert S. Mosser Award for Excellence in Internal Medicine, U.C.L.A. School of Medicine (May 1990)
· Granted U.S. Patent 10,335,396 for Methods of Reversing Chronic Autonomic Nervous System Damage (July 2019)
· Trademark protection granted for “The Nemechek Protocol,” the name used to describe the treatment program invented to reverse chronic autonomic dysfunction (July 2017)
· Granted U.S. Patent 11,123,560 for Methods of Treating Covid-19 Induced Cytokine Storm (September 2021)
· Patent Pending for System and Methods for Treating Autism Spectrum Disorder, Developmental Disorders, and Other Medical Conditions (March 2023)
· “The Nemechek Protocol™ for Autism and Developmental Disorders” by Nemechek P., Nemechek J., Autonomic Recovery Publications, July 2017
· “The Nemechek Protocol™ for Autism and Developmental Disorders, 2nd Edition” by Nemechek P., Nemechek J., Autonomic Recovery Publications, June 2021
· “The Nemechek Protocol™ for ADD, POTS, PANS, PANDAS and Emotional Dysregulation” by Nemechek P., Nemechek J., Autonomic Recovery Publications, November 2023
· Dr. Nemechek is author or co-author in 81 peer-reviewed research papers and post presentations.
Dr. Nemechek was Principle Investigator or Co-Investigator in 41 clinical trials.
· Review Dr. Nemechek Complete Curriculum Vitae
The Protocol Recovery Starter Pack + Free Nemechek Navigator Access includes The Nemechek Protocol™ Book, Nemechek Gold Olive Oil, Nemechek Blue Inulin, and Nemechek Silver Fish Oil, a dosing guide, a measuring spoon and free access to Nemechek Navigator. Everything needed to begin the path to recovery.